跳至主要内容
临床试验/CTRI/2024/07/071455
CTRI/2024/07/071455尚未招募不适用

A prescription audit of mood stabilizers, antipsychotics and antidepressants in clinically stable patients with bipolar depression: a cross sectional study

Dr Nithin Rajendran1 个研究点 分布在 1 个国家目标入组 93 人开始时间: 2024年8月22日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
93
试验地点
1
主要终点
Prescription audit with respect to WHO core drug use indicators-

研究概览

简要总结

To study Prescription audit in clinically stable patients diagnosed with bipolar depression focusing on the usage of mood stabilizers, antipsychotics and antidepressants. All the patients of bipolar depression attending the OPD of Psychiatry in Rajindra Hospital, Patiala, will be screened according to the inclusion and exclusion criteria.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients will be adults (aged 18 years and above) diagnosed with bipolar depression as per standardized diagnostic criteria (e.g., DSM-5).
  • Patients who will be medically stable.
  • Patients of either sex 4)Participants actively receiving treatment for bipolar depression during the study period.
  • Patients who will be accompanied by reliable informants.
  • Patients and informants who give written informed consent and are willing participate in the study.

排除标准

  • Individuals with acute manic or depressive episodes, as the focus is on clinically stable patients.
  • Those with a history of recent hospitalizations or significant disruptions in treatment adherence, as these factors may act as confounders.
  • Patients with comorbid psychiatric conditions that significantly impact the assessment of bipolar depression prescription audit.
  • Participants unable or unwilling to provide informed consent.
  • Patients having insufficient data or records.
  • Pregnant and lactating women.

结局指标

主要结局

Prescription audit with respect to WHO core drug use indicators-

时间窗: 2 Years

1.Prescribing indicators

时间窗: 2 Years

2.Patient-care indicators

时间窗: 2 Years

3.Health facility indicators

时间窗: 2 Years

次要结局

  • Prevalence of polypharmacy(2 Years)

研究者

发起方
Dr Nithin Rajendran
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Nithin Rajendran

Government Medical College

研究点 (1)

Loading locations...

相似试验